logo

For the Inventor, By the Inventor

Hayward, CA, United States of America

Aradigm Corporation


USPTO Granted Patents = 130

% Expired Patents = 30.8



Trademarks = 3

Forward Citations = 9,830

Loading Chart...
Loading Chart...

42 inventors (with patents filed for the assignee):

goldMedal Reid M Rubsamen (67 out of 75 patents)

silverMedal Igor Gonda (44 out of 54 patents)

bronzeMedal Jeffrey A Schuster (30 out of 43 patents)

4.  Lester John Lloyd (23 out of 47 patents)

5.  Stephen J Farr (20 out of 32 patents)

6.  Peter M Lloyd (17 out of 18 patents)

7.  David C Cipolla (16 out of 21 patents)

8.  James Blanchard (13 out of 15 patents)

9.  Sudarsan Srinivasan (12 out of 12 patents)

10.  Rajesh S Patel (12 out of 28 patents)

11.  Eric T Johansson (10 out of 28 patents)

12.  Carl Ritson (8 out of 29 patents)

13.  Christopher J Flaim (6 out of 8 patents)

14.  David E Goodman (5 out of 16 patents)

15.  Thor Miller Wilbanks (3 out of 5 patents)


Core Competencies:
Aerosol Drug Delivery
Ciprofloxacin Formulation
Liposomal Formulations
Inhaled Insulin
Smoking Cessation
Nanocrystals
Pulmonary Delivery
Temperature Control
Non-destructive Analysis
Drug Nanocrystals
Tobacco Use
Porous Membrane

130 patents:

1. 10420765 - Concentrated, inhalable ciprofloxacin formulation (2019-09-24),
2. 10376508 - Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria (2019-08-13),
3. 9987227 - Inhaled surfactant-modified liposomal formulations providing both an immediate and sustained release profile (2018-06-05),
4. 9968555 - Liposomal formulations that form drug nanocrystals after freeze-thaw (2018-05-15),
5. 9857387 - Diagnosis of entry of gastrointestinal contents into respiratory tract of humans and animals (2018-01-02),
6. 9844548 - Liposomal ciprofloxacin formulations with encapsulated ciprofloxacin nanocrystals (2017-12-19),
7. 9592220 - Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tract (2017-03-14),
8. 9545401 - Concentrated, inhalable ciprofloxacin formulation (2017-01-17),
9. 9532986 - Liposomal ciprofloxacin formulations with activity against non-tuberculous mycobacteria (2017-01-03),
10. 9511199 - Pore structures for reduced pressure aerosolization (2016-12-06),
11. 9457006 - Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tract (2016-10-04),
12. 9421185 - Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tract (2016-08-23),
13. 9372198 - Diagnosis of entry of gastrointestinal contents into respiratory tract of humans and animals (2016-06-21),
14. 9259424 - Concentrated, inhalable antibiotic formulation (2016-02-16),
15. 9078897 - Concentrated, inhalable antibiotic formulation (2015-07-14),
Aradigm Corporation is a specialty pharmaceutical company focused on the development and commercialization of innovative drugs for the treatment of severe respiratory diseases. They are dedicated to improving patient outcomes by offering unique therapeutic solutions. Visit their website to learn more about their products and initiatives.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

Aradigm Corporation
130 Patents

#1 in Hayward, CA

#667 in California

#2,973 in US

#6,167 in the World

Hayward, CA (US)
Hayward, CA, United States of America

Aradigm Corporation

Forward Citations = 9,830

42 inventors:

goldMedal Reid M Rubsamen (67 out of 75 patents)

silverMedal Igor Gonda (44 out of 54 patents)

bronzeMedal Jeffrey A Schuster (30 out of 43 patents)

4.  Lester John Lloyd (23 out of 47 patents)

5.  Stephen J Farr (20 out of 32 patents)

Please report any incorrect information to [email protected]
Loading…